TJX, Sysco, Lululemon And A Healthcare Stock On CNBC's 'Final Trades'

On CNBC's “Halftime Report Final Trades,” Brenda Vingiello of Sand Hill Global Advisors named The TJX Companies, Inc. TJX as her final trade.

On May 22, TJX Companies reported better-than-expected first-quarter financial results.

The Framingham, Massachusetts-based company reported first-quarter FY25 sales growth of 5.9% year-on-year to $12.479 billion, beating the analyst consensus estimate of $12.463 billion. Overall comp store sales increased 3%. EPS of 93 cents beat the consensus estimate of 87 cents.

Jim Lebenthal of Cerity Partners picked AbbVie Inc. ABBV, another contrarian play.

On May 31, AbbVie said it received positive CHMP opinion for risankizumab (SKYRIZI®) for the treatment of adults with moderately to severely active ulcerative colitis.

Don't forget to check out our premarket coverage here

Jenny Van Leeuwen Harrington of Gilman Hill Asset Management, LLC named Sysco Corporation SYY.

On April 30, Sysco reported third-quarter FY24 sales growth of 2.7% year-on-year to $19.38 billion, missing the analyst consensus estimate of $19.74 billion.

Rob Sechan of NewEdge Wealth picked Lululemon Athletica Inc. LULU as his final trade.

On May 21, Lululemon Athletica announced an updated operational structure following the resignation of its chief product officer. The company announced that chief product officer Sun Choe has resigned from his role and will depart the company later this month to pursue other opportunities.

Price Action:

• TJX shares fell 0.3% to close at $103.10 on Friday.
• AbbVie shares gained 3.2% to settle at $161.24 during Friday's session.
• Sysco shares rose 1.6% to close at $72.82 during Friday's session.
• Lululemon shares climbed 3% to settle at $311.95 on Friday.

Check This Out: Over $8M Bet On This Health Care Stock? Check Out These 4 Stocks Insiders Are Buying